TCDD-Up-Regulation of IGFBP-6 and IL-5R Alpha Subunit Genes in Vivo and in Vitro

Molecules and Cells

Volumn 12, Issue 3, 2001, Pages 372-379

  Park, Joo Hung ^a   Lee, Soo Woong ^a   Kim, In Taek ^a   Shin, Byung Shik ^a   Cheong, Seon Woo ^a   Cho, Un Haing ^a   Huh, Min Jung ^a   Oh, Gap Soo ^a  

^a Changwon National University   (South Korea)

Author keywords

IGFBP 6; IL 5R alpha; TCDD; Up Regulation

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; INTERLEUKIN 5 RECEPTOR; INTERLEUKIN RECEPTOR; SOMATOMEDIN BINDING PROTEIN 6; TERATOGENIC AGENT;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BONE MARROW; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; METABOLISM; MOUSE; THYMUS; UPREGULATION;

ANIMALS; BONE MARROW; GENE EXPRESSION REGULATION; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 6; MICE; MICE, INBRED BALB C; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-5; TERATOGENS; TETRACHLORODIBENZODIOXIN; THYMUS GLAND; UP-REGULATION;

EID: 0035981235     PISSN: 10168478     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Bach, L. A. (1999) Insulin-like growth factor binding protein-6: the 'forgotten' binding protein? Horm. Metab. Res. 31, 226-234.
2. Bach, L. A. and Rechler, M. M. (1995) Insulin-like growth factor binding proteins. Diabetes Rev. 3, 38-61.
3. Burbach, K. M., Poland, A., and Bradfield, C. A. (1992) Cloning of the Ah-receptor cDNA reveals a distinctive ligand-activated transcription factor. Proc. Natl. Acad. Sci. USA 89, 8185-8189.
4. DeKrey, G. K. and Kerkvliet, N. I. (1995) Suppression of cytotoxic T lymphocyte activity by 2,3,7,8-tetrachlorodibenzo-p-dioxin occurs in vivo, but not in vitro, and is independent of corticosterone elevation. Toxicology 97, 105-112.
5. b gene expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin. J. Biol. Chem. 272, 29614-29619.
6. Favreau, L. V. and Pickett, C. B. (1991) Transcriptional regulation of the rat NAD(P)H: quinone reductase gene. Identification of regulatory elements controlling basal level expression and inducible expression by planar aromatic compounds and phenolic antioxidants. J. Biol. Chem. 266, 4556-4561.
7. Greiller, P., De Galle, B., and Babajko, S. (1998) Expression of insulin-like growth factor-binding protein 6 complementary cDNA alters neuroblastoma cell growth. Cancer Res. 58, 1670-1676.
8. + B cells. J. Immunol. 144, 4218-4225.
9. Hoffer, A., Chang, C.-Y., and Puga, A. (1996) Dioxin induces transcription of fos and jun genes by Ah receptor-dependent and -independent pathways. Toxicol. Appl. Pharmacol. 141, 238-247.
10. Huff, J., Lucier, G., and Tritscher, A. (1994) carcinogenecity of TCDD: experimental, mechanistic, and epidemiological evidence. Annu. Rev. Pharmacol. Toxicol. 34, 343-372.
11. Jones, J. I. and Clemmons, D. R. (1995) Insulin-like growth factors and their binding proteins: biological actions. Endocr. Rev. 16, 3-34.
12. Kamath, A. B., Camacho, I., Nagarkatti, P. S., and Nagarkatti, M. (1999) Role of Fas-Fas ligand interactions in 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-induced immunotoxicity: increased resistance of thymocytes from Fas-deficient (lpr) and Fas ligand-defective (gld) mice to TCDD-induced toxicity. Toxicol. Appl. Pharmacol. 160, 141-155.
13. Kerkvliet, N. I. and Oughton, J. A. (1993) Acute inflammatory response to SRBC in mice treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD): phenotypic and functional analysis of peritoneal exudate cells. Toxicol. Appl. Pharmacol. 119, 248-257.
14. Kerkvliet, N. I., Baecher-Steppan, L., Shepherd, D. M., Oughton, J. A., Vorderstrasse, B. A., and DeKrey, G. K. (1996) Inhibition of TC-1 cytokine production, effector cytotoxic T lymphocyte development and alloantibody production by 2,3,7,8-tetrachlorodibenzo-p-dioxin. J. Immunol. 157, 2310-2319.
15. Kerkvliet, N. L. and Burleson, G. R. (1994) Immunotoxicity of TCDD and related halogenated aromatic hydrocarbons; in Immonotoxicology and Immunopharmacology, Dean, J. H., Luster, M. I., Munson, A. E., and Kimber, I. (eds.), pp. 97-121, Raven Press, NY.
16. Kip1 induction and inhibition of proliferation by the intracellular Ah receptor in developing thymus and hepatoma cells. Genes Dev. 13, 1742-1753.
17. Kremer, J., Gleichmann, E., and Esser, C. (1994) Thymic stroma exposed to arylhydrocarbon receptor-binding xenobiotics fails to support proliferation of early thymocytes but induces differentiation. J. Immunol. 153, 2778-2786.
18. Ku, H. and Meier, K. E. (2000) Phosphorylation of paxillin via the ERK mitogen-activated protein kinase cascade in EL4 thymoma cells. J. Biol. Chem. 275, 11333-11340.
19. Lang, D. S., Becker, S., Clark, G. C., Delvin, R. B., and Koren, H. S. (1994) Lack of direct immunosuppressive effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on human peripheral blood lymphocyte subsets in vitro. Arch. Toxicol. 68, 296-302.
20. Lee, J. H., Sung, B. W., Youn, H. J., and Park, J. H. (2000) Identification, expression, and nuclear location of murine Mage-b2 protein, a tumor-associated antigen. Mol. Cells 10, 647-653.
21. Lu, Y.-F., Sun, G., Wang, X., and Safe, S. (1996) Inhibition of prolactin receptor gene expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin in MCF-7 human breast cancer cells. Arch. Biochem. Biophys. 332, 35-40.
22. Mann, K. K., Matulka, R. A., Hahn, M. E., Trombino, A. F., Lawrence, B. P., Kerkvliet, N. I., and Sherr, D. H. (1999) The role of polycyclic aromatic hydrocarbon metabolism in dimethylbenz[a]anthracene-induced pre-B lymphocyte apoptosis. Toxicol. Appl. Pharmacol. 161, 10-22.
23. Mann, K. K., Doerre, S., Schlezinger, J. J., Sherr, D. H., and Quadri, S. (2001 ) The role of NF-kappaB as a survival factor in environmental chemical-induced pre-B cell apoptosis. Mol. Pharmacol. 59, 302-309.
24. Mantovani, A., Vecchi, A., Luini, W., Sironi, M., Candiani, G. P., Sprealico, F., and Garattini, S. (1980) Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on macrophage and natural killer cell mediated cytotoxicity in mice. Biomedicine 32, 200-204.
25. Nagata, T., Kishi, H., Liu, Q. L., Yoshino, T., Matsuda. T., Jin, Z. X., Murayama, K., Tsukada, K., and Muraguchi, A. (2000) Possible involvement of cyclophilin B and caspase-activated deoxyribonuclease in the induction of chromosomal DNA degradation in TCR-stimulated thymocytes. J. Immunol. 165, 4281-4289.
26. Oh, Y., Nagalla, S. R., Yamanaka, Y., Kim, H.-S., Wilson, E., and Rosenfeld, R. G. (1996) Synthesis and characterization of insulin-like growth factor-binding protein (IGFBP)-7: recombinant human mac25 protein specifically binds IGF-I and -II. J. Biol. Chem. 271, 30322-30325.
27. Poland, A. and Knutson, J. C. (1982) 2,3,7,8-tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons: examination of the mechanism of toxicity. Ann. Rev. Pharmacol. Toxicol. 22, 517-554.
28. Prell, R. A. and Kerkvliet. N. I. (1997) Involvement of altered B7 expression in dioxin immunotoxicity: B7 transfection restores the CTL but not the alloantibody response to the P815 mastocytoma. J. Immunol. 158, 2695-2703.
29. Prell, R. A., Dearstyne, E., Steppan, L. G., Vella, A. T., and Kerkvliet, N. I. (2000) CTL hyporesponsiveness induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin: role of cytokines and apoptosis. Toxicol. Appl. Pharmacol. 166, 214-221.
30. Pryputniewicz, S. J., Nagarkatti, M., and Nagarkatti, P. S. (1998) Differential induction of apoptosis in activated and resting T cells by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and its repercussion on T cell responsiveness. Toxicology 129, 211-226.
31. Puga, A., Barnes, S. J., Chang, C., Zhu, H., Nephew, K. P., Khan, S. A., and Shertzer, H. G. (2000) Activation of transcription factors activator protein- and nuclear factor-kappa B by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Biochem. Pharmacol. 59, 997-1005.
32. Rushmore, T. H. and Pickett, C. B. (1990) Transcriptional regulation of the rat glutathione S-transferase Ya subunit gene: characterization of a xenobiotic-responsive element controlling inducible expression by phenolic antioxidants. J. Biol. Chem. 265, 14648-14653.
33. Schmid, C., Keller, C., Gosteli-Peter, M., and Zapf, J. (1999) Mitogenic and antiapoptotic effects of insulin-like growth factor binding protein-6 in the human osteoblastic osteosarcoma cell line Saos-2/B-10. Biochem. Biophys. Res. Commun. 179, 579-585.
34. Schrader, J. W. (1994) Interleukin-5; in The Cytokine Handbook, Thompson, A. (ed.), pp. 127-144, Academic Press, San Diego, CA.
35. Staples, J. E., Fiore, N. C., Frazier, D. E. Jr., Gasiewicz, T. A., and Silverstone, A. E. (1998a) Overexpression of the antiapoptotic oncogene, bcl-2, in the thymus does not prevent thymic atrophy induced by estradiol or 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol. Appl. Pharmacol. 151, 200-210.
36. Staples, J. E., Murante, F. G., Flore, N. C., Gasiewicz, T. A., and Silverstone, A. E. (1998b) Thymic alterations induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin are strictly dependent on aryl hydrocarbon receptor activation in hemopoietic cells. J. Immunol. 160, 3844-3854.
37. Sueoka, N., Lee, H. Y., Wiehle, S., Cristiano, R. J., Fang, B., Ji, L., Roth, J. A., Hong, W. K., Cohen, P., and Kurie, J. M. (2000a) Insulin-like growth factor binding protein-6 activates programmed cell death in non-small cell lung cancer cells. Oncogene 19, 4432-4436.
38. Sueoka, N., Lee, H. Y., Walsh, G. L., Fang, B., Ji, L., Roth, J. A., LaPushin, P., Cohen, P., and Kurie, J. M. (2000b) Insulin-like growth factor binding protein-6 inhibits the growth of human bronchial epithelial cells and increases in abundance by all-trans-retinoic acid treatment. Am. J. Respir. Cell Mol. Biol. 23, 297-303.
39. Swanson, H. I. and Bradfield, C. A. (1993) The AH-receptor: genetics, structure and function. Pharmacogenetics 3, 213-230.
40. + eosinophils in the murine thymus: developmental regulation and recruitment upon MHC class I-restricted thymocyte deletion. J. Immunol. 165, 1965-1975.
41. Tomaki, M., Zhao, L. L., Sjostrand, M., Jordana, M., Linden, A., O'Byrne, P., and Lotvall, J. (2000) Eosinophilopoiesis in a murine model of allergic airway eosinophilia: involvement of bone marrow IL-5 and IL-5 receptor alpha. J. Immunol. 165, 4040-4050.
42. Tritscher, A. M., Goldstein, J. A., Portier, C. J., McCoy, Z., Clark, G. C., and Lucier, G. W. (1992) Dose-response relationships for chronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin in a rat tumor promotion model: quantitation and immunolocalization of CYP1A1 and CYP1A2 in the liver. Cancer Res. 52, 3436-3442.
43. Vorderstrasse, B. A. and Kerkvliet, N. I. (2001) 2,3,7,8-tetrachlorodibenzo-p-dioxin affects the number and function of murine splenic dendritic cells and their expression of accessory molecules. Toxicol. Appl. Pharmacol. 171, 117-125.
44. Wang, F., Wang, W., and Safe, S. (1999) Regulation of constitutive gene expression through interactions of SpI protein with the nuclear aryl hydrocarbon receptor complex. Biochemistry 38, 11490-11500.
45. Weber, J. S. and Rosenberg, S. A. (1988) Modulation of murine tumor major histocompatibility antigens by cytokines in vivo and in vitro. Cancer Res. 48, 5818-5824.
46. Weller, M., Constam, D. B., Malipiero, U., and Fontana, A. (1994) Transforming growth factor-beta 2 induces apoptosis of murine T cell clones without down-regulating bcl-2 mRNA expression. Eur. J. Immunol. 24, 1293-1300.
47. Wright, S. D., Ramos, R. A., Tobias, P. S., Ulevitch, R. J., and Mathison, J. C. (1990) CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249, 1431-1433.